Testing for HIV Integrase Inhibitor Resistance: 2025 and Beyond

Join this comprehensive webinar featuring experts Dr. Gert van Zyl, Dr. Rami Kantor, Dr. Urvi Parikh, and Dr. Steve Williams as they discuss the critical issue of HIV integrase inhibitor resistance testing and its future beyond 2025. Learn about the increasing prevalence of drug-resistant HIV strains, which the WHO estimates affects approximately 10% of people initiating antiretroviral treatment globally. Explore how HIV drug resistance emerges with antiretroviral drug use for both treatment and prevention, and understand the factors contributing to resistance including incomplete adherence, suboptimal drug availability, and transmission of resistant strains. Gain insights into current drug resistance testing methods for public health surveillance and clinical management of persons living with HIV, while examining emerging challenges in detection and monitoring of HIV drug resistance from leading experts in the field.